MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/mdc3.70411

Медицинская библиотека · Movement disorders clinical practice · 2025

Motor and Cognitive Outcome After Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease Harboring GBA1 Variant.

Kamo Hikaru, Oyama Genko, Shimizu Mai, Takeshige-Amano Haruka, Ogawa Takashi, Sako Wataru, Nishikawa Noriko, Hatano Taku, Li Yuanzhe, Yoshino Hiroyo, Funayama Manabu, Ito Masanobu, Iwamuro Hirokazu, Umemura Atsushi, Hattori Nobutaka

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Deep brain stimulation (DBS) is effective for Parkinson's disease (PD); however, its efficacy varies with genetic background, such as the GBA1 variant-the causative gene of Gaucher disease-associated with increased PD risk and cognitive decline after subthalamic nucleus (STN)-DBS.

OBJECTIVES

The aim of the study was to examine the relationship between outcomes after STN-DBS and GBA1 variants in PD patients undergoing bilateral STN-DBS.

METHODS

Patients were retrospectively analyzed over 5 years, with clinical and genetic assessments, including GBA1 variant status performed at baseline and at 1-, 3-, and 5-years post-DBS. Longitudinal changes in motor, cognitive, and medication outcomes were evaluated using propensity score matching and linear mixed-effects models.

RESULTS

A total of 371 PD patients undergoing bilateral STN-DBS were analyzed, including 54 GBA1 variant carriers and 253 noncarriers, after excluding other genetic variants. Propensity score matching yielded 2 groups with balanced baseline characteristics, with 50 patients each. Over time, no significant differences were observed in motor, cognitive, or neuropsychiatric assessments between groups. GBA1 carriers exhibited worsened medication OFF-DBS off state motor symptoms at 5 years postoperatively, whereas cognitive function, assessed by the Mini-Mental State Examination, remained stable in both groups. Levodopa-equivalent daily dose (LEDD) significantly decreased in both groups. Linear mixed-effects models showed progressive motor and cognitive decline and reduced medication use over 5 years, with no significant impact on GBA1 variant status.

CONCLUSIONS

Findings from Japan's largest genetic cohort suggest that GBA1 variants may not significantly affect postoperative motor or cognitive trajectories following STN-DBS. Further validation through large-scale multinational and multicenter studies is warranted.

Для цитирования: Kamo Hikaru, Oyama Genko, Shimizu Mai, Takeshige-Amano Haruka, Ogawa Takashi, Sako Wataru, Nishikawa Noriko, Hatano Taku, Li Yuanzhe, Yoshino Hiroyo, Funayama Manabu, Ito Masanobu, Iwamuro Hirokazu, Umemura Atsushi, Hattori Nobutaka. Motor and Cognitive Outcome After Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's Disease Harboring GBA1 Variant.. Movement disorders clinical practice. 2025. DOI: 10.1002/mdc3.70411.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.